These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 26772823)
1. Cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma. Haghpanah V; Fallah P; Naderi M; Tavakoli R; Soleimani M; Larijani B Life Sci; 2016 Feb; 146():34-9. PubMed ID: 26772823 [TBL] [Abstract][Full Text] [Related]
2. In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines. Zito G; Richiusa P; Bommarito A; Carissimi E; Russo L; Coppola A; Zerilli M; Rodolico V; Criscimanna A; Amato M; Pizzolanti G; Galluzzo A; Giordano C PLoS One; 2008; 3(10):e3544. PubMed ID: 18958156 [TBL] [Abstract][Full Text] [Related]
3. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells. Tseng LM; Huang PI; Chen YR; Chen YC; Chou YC; Chen YW; Chang YL; Hsu HS; Lan YT; Chen KH; Chi CW; Chiou SH; Yang DM; Lee CH J Pharmacol Exp Ther; 2012 May; 341(2):410-23. PubMed ID: 22328572 [TBL] [Abstract][Full Text] [Related]
4. Multiple pluripotent stem cell markers in human anaplastic thyroid cancer: the putative upstream role of SOX2. Carina V; Zito G; Pizzolanti G; Richiusa P; Criscimanna A; Rodolico V; Tomasello L; Pitrone M; Arancio W; Giordano C Thyroid; 2013 Jul; 23(7):829-37. PubMed ID: 23301671 [TBL] [Abstract][Full Text] [Related]
5. The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics. Liu A; Feng B; Gu W; Cheng X; Tong T; Zhang H; Hu Y Int J Oncol; 2013 Apr; 42(4):1399-407. PubMed ID: 23416969 [TBL] [Abstract][Full Text] [Related]
6. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics. Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma. Liu J; Brown RE Int J Clin Exp Pathol; 2010 Oct; 3(8):755-62. PubMed ID: 21151388 [TBL] [Abstract][Full Text] [Related]
8. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer. Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531 [TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of CD133+ cancer stem-like cells in endometrial cancer. Nakamura M; Zhang X; Mizumoto Y; Maida Y; Bono Y; Takakura M; Kyo S Int J Oncol; 2014 Mar; 44(3):669-77. PubMed ID: 24366104 [TBL] [Abstract][Full Text] [Related]
10. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells. Jia Q; Zhang X; Deng T; Gao J Cell Reprogram; 2013 Apr; 15(2):143-50. PubMed ID: 23438193 [TBL] [Abstract][Full Text] [Related]
11. Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer. Haghpanah V; Fallah P; Tavakoli R; Naderi M; Samimi H; Soleimani M; Larijani B Tumour Biol; 2016 Jan; 37(1):1299-308. PubMed ID: 26289851 [TBL] [Abstract][Full Text] [Related]
12. Targeting the BRAF Signaling Pathway in CD133pos Cancer Stem Cells of Anaplastic Thyroid Carcinoma. Bozorg-Ghalati F; Hedayati M; Dianatpour M; Mosaffa N; Azizi F Asian Pac J Cancer Prev; 2019 May; 20(5):1353-1360. PubMed ID: 31127889 [TBL] [Abstract][Full Text] [Related]
13. Expression of cancer stem cell markers and epithelial-mesenchymal transition-related factors in anaplastic thyroid carcinoma. Jung CW; Han KH; Seol H; Park S; Koh JS; Lee SS; Kim MJ; Choi IJ; Myung JK Int J Clin Exp Pathol; 2015; 8(1):560-8. PubMed ID: 25755746 [TBL] [Abstract][Full Text] [Related]
14. Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome. Yun JY; Kim YA; Choe JY; Min H; Lee KS; Jung Y; Oh S; Kim JE J Clin Pathol; 2014 Feb; 67(2):125-33. PubMed ID: 23986551 [TBL] [Abstract][Full Text] [Related]
15. Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Okamoto A; Chikamatsu K; Sakakura K; Hatsushika K; Takahashi G; Masuyama K Oral Oncol; 2009 Jul; 45(7):633-9. PubMed ID: 19027347 [TBL] [Abstract][Full Text] [Related]
16. Illuminating the role of lncRNAs ROR and MALAT1 in cancer stemness state of anaplastic thyroid cancer: An exploratory study. Mahdiannasser M; Khazaei S; Akhavan Rahnama M; Soufi-Zomorrod M; Soutodeh F; Parichehreh-Dizaji S; Rakhsh-Khorshid H; Samimi H; Haghpanah V Noncoding RNA Res; 2023 Sep; 8(3):451-458. PubMed ID: 37455764 [TBL] [Abstract][Full Text] [Related]
17. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma. Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma. Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447 [TBL] [Abstract][Full Text] [Related]
19. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis. Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631 [TBL] [Abstract][Full Text] [Related]